Infertility Evaluation & Treatment in Dubai | Fertility Specialist

Comprehensive infertility evaluation and treatment in Dubai. Expert fertility specialists offering ovulation induction, IUI, PRP therapy, laparoscopic surgery, and advanced reproductive care for couples trying to conceive.

Expert Fertility Care for Couples Trying to Conceive

Infertility affects approximately 15% of couples worldwide, defined as inability to conceive after 12 months of regular unprotected intercourse (or 6 months if woman is over 35 years old). At our Dubai clinic, board-certified reproductive endocrinologists and fertility specialists provide comprehensive evaluation and evidence-based treatment following American Society for Reproductive Medicine (ASRM) and European Society of Human Reproduction and Embryology (ESHRE) guidelines. We offer personalized fertility care addressing female factors (ovulatory disorders, tubal disease, endometriosis, uterine abnormalities), male factors (low sperm count, poor motility, abnormal morphology), and unexplained infertility with compassionate, culturally sensitive approach understanding the emotional journey of fertility treatment.

What Does Infertility Evaluation and Treatment Involve?

Comprehensive fertility evaluation includes detailed reproductive history for both partners assessing menstrual cycle regularity, previous pregnancies, contraception history, sexual frequency and timing, previous fertility treatments, medical and surgical history, medications, lifestyle factors (smoking, alcohol, weight, exercise, stress). Female testing: ovarian reserve assessment (AMH, day 3 FSH/LH/estradiol), ovulation confirmation (mid-luteal progesterone, basal body temperature charting, ovulation predictor kits), tubal patency evaluation (hysterosalpingography HSG or saline sonography), pelvic ultrasound assessing uterine and ovarian anatomy, hysteroscopy if indicated for uterine cavity evaluation, thyroid function (TSH), prolactin screening. Male testing: semen analysis (two samples, WHO criteria for count, motility, morphology), hormonal evaluation if severe abnormalities (testosterone, FSH, LH). Treatment options range from simple interventions (timed intercourse coaching, lifestyle optimization, ovulation induction with Clomid or Letrozole) to advanced procedures (intrauterine insemination IUI, laparoscopic surgery for endometriosis or tubal disease, ovarian drilling for PCOS, PRP ovarian rejuvenation therapy, referral for IVF/ICSI if indicated). Multidisciplinary approach coordinates care with andrologist for male factor, reproductive immunologist if recurrent miscarriage, genetic counselor if chromosomal concerns.

Who Needs Fertility Evaluation?

Couples unable to conceive after 12 months of regular unprotected intercourse (or 6 months if woman age 35+)
Women with irregular or absent menstrual periods suggesting ovulatory dysfunction (PCOS, hypothalamic amenorrhea)
History of pelvic inflammatory disease, endometriosis, or previous pelvic surgery potentially affecting tubes
Known uterine abnormalities: fibroids, polyps, septate uterus, Asherman syndrome (intrauterine adhesions)
Male partner with known fertility issues: previous semen analysis abnormalities, history of undescended testes, varicocele, chemotherapy
Recurrent pregnancy loss: two or more consecutive miscarriages requiring investigation
Advanced maternal age: women 35-40 years old should seek evaluation after 6 months; over 40 immediately
Previous cancer treatment with chemotherapy or pelvic radiation potentially affecting fertility
Couples with genetic disorders requiring preimplantation genetic testing PGT
Same-sex female couples or single women seeking donor sperm insemination

Benefits of Professional Fertility Care

Accurate diagnosis identifying specific cause of infertility enables targeted treatment improving success rates
Ovulation induction achieves 20-30% pregnancy rate per cycle for anovulatory women (PCOS, hypothalamic amenorrhea)
Tubal surgery or endometriosis treatment restores natural conception potential avoiding IVF in many cases
Intrauterine insemination IUI doubles pregnancy rates compared to timed intercourse for unexplained infertility, mild male factor
Early intervention for age-related decline: fertility preservation counseling, expedited treatment maximizing remaining egg quality
Male factor treatment: lifestyle optimization, antioxidants, varicocele repair improving sperm parameters 30-50%
Emotional support and counseling throughout fertility journey reducing stress and improving coping
Evidence-based approach avoiding ineffective treatments, unnecessary procedures, optimizing time and cost-effectiveness
Coordination with IVF centers for seamless transition if advanced reproductive technology needed
Comprehensive care addressing contributing factors: thyroid disorders, hyperprolactinemia, diabetes, obesity, stress

Preparing for Your Fertility Consultation

Important Preparation Guidelines:

Track menstrual cycles for 2-3 months prior noting cycle length, ovulation signs (cervical mucus, ovulation predictor kit results)
Bring previous medical records including prior fertility testing, semen analyses, ultrasound reports, surgical records
List all current medications, supplements, vitamins both partners are taking
Document sexual frequency and timing relative to ovulation attempts
Male partner should abstain from ejaculation 2-5 days before semen analysis (optimal for testing)
Schedule HSG (tubal test) for days 5-10 of menstrual cycle (after period ends, before ovulation)
Both partners attend initial consultation whenever possible for comprehensive evaluation
Prepare questions: write concerns and questions beforehand to ensure everything addressed
Consider lifestyle factors: maintain healthy BMI, avoid smoking/alcohol, reduce caffeine, manage stress
Understand insurance coverage: verify fertility testing and treatment benefits before scheduling procedures

What to Expect During Your Visit

1Before the Exam

•Detailed history intake for both partners: reproductive, medical, surgical, family, social history
•Discussion of timeline: how long trying to conceive, frequency of intercourse, ovulation tracking methods
•Review of menstrual history: cycle regularity, flow, pain, prior contraception use and duration
•Assessment of risk factors: age, weight, smoking, alcohol, previous STIs, surgeries, medications
•Education about normal fertility: fertile window, conception probability per cycle, factors affecting success
•Explanation of testing plan: which tests needed, timing, what results mean, next steps based on findings

2During the Exam

•Female pelvic examination: assessment of uterine size, mobility, adnexal masses, cervical abnormalities
•Transvaginal ultrasound: evaluating uterine cavity, endometrial thickness, ovarian follicle count, cysts, fibroids
•Blood draw: hormonal panel timed to specific cycle days (day 3 for FSH/LH/estradiol/AMH, day 21 for progesterone)
•Semen analysis collection: private collection room provided, sample analyzed within 1 hour for accuracy
•Hysterosalpingography HSG scheduling: X-ray dye test checking fallopian tube patency, uterine cavity shape
•Sonohysterography option: saline infusion ultrasound alternative to HSG providing detailed uterine cavity visualization
•Discussion during exam: explaining findings in real-time, answering questions, providing reassurance

3After the Exam

•Results review: comprehensive discussion of all testing findings, diagnosis, prognosis
•Treatment plan development: personalized approach based on diagnosis, age, duration of infertility, patient preferences
•Ovulation induction protocol: if anovulatory, prescribing Clomid or Letrozole with monitoring plan
•IUI coordination: if indicated, scheduling insemination with ovulation monitoring, sperm preparation
•Surgical referral: if endometriosis, tubal disease, fibroids require laparoscopy or hysteroscopy
•Lifestyle counseling: weight optimization, nutrition, exercise, stress reduction, supplement recommendations
•Male factor intervention: urologist referral, antioxidant therapy, varicocele evaluation if semen analysis abnormal
•IVF consultation: if advanced treatment needed, coordinating referral to reproductive endocrinology IVF center
•Follow-up scheduling: cycle monitoring visits, post-treatment assessment, pregnancy testing
•Emotional support resources: counseling referrals, support groups, fertility community connections

Why Choose Our Dubai Fertility Services?

Board-Certified Fertility Specialists

Our reproductive endocrinologists and gynecologists have specialized fellowship training in reproductive medicine from internationally recognized programs. We stay current with latest fertility research, attend annual ASRM and ESHRE conferences, and implement evidence-based protocols proven to maximize pregnancy success rates. Our expertise spans ovulatory disorders, endometriosis, tubal disease, male factor infertility, recurrent pregnancy loss, and advanced maternal age fertility preservation.

Comprehensive Diagnostic Capabilities

State-of-the-art fertility testing available in-house: advanced hormonal assays (AMH, inhibin B, anti-Müllerian hormone), high-resolution transvaginal ultrasound with 3D capability, hysterosalpingography HSG, sonohysterography, office hysteroscopy, andrology laboratory for semen analysis and sperm function testing. Same-day results for most tests enabling rapid diagnosis and treatment initiation. Coordination with genetic testing laboratories for karyotype analysis, carrier screening, preimplantation genetic testing PGT when indicated.

Personalized Treatment Protocols

We recognize every couple's fertility journey is unique. Treatment plans individualized based on specific diagnosis, age, ovarian reserve, duration of infertility, previous treatment history, cultural considerations, and personal preferences. Options range from conservative (timed intercourse optimization, lifestyle modification) to moderate interventions (ovulation induction, IUI) to surgical correction (laparoscopy for endometriosis, tubal repair, fibroid removal) to advanced technology referrals (IVF, ICSI, donor eggs/sperm). We believe in stepwise approach—starting with least invasive, most cost-effective treatments appropriate for diagnosis before advancing to complex procedures.

Ovulation Induction Expertise

Clomiphene citrate (Clomid) and Letrozole ovulation induction our specialty—achieving 70-80% ovulation rates and 20-30% pregnancy rates per cycle for anovulatory women with PCOS or hypothalamic amenorrhea. Careful monitoring with ultrasound and estradiol levels prevents dangerous complications: ovarian hyperstimulation syndrome OHSS, high-order multiple pregnancies. Trigger timing optimized with hCG injection or natural LH surge confirmation. We also offer injectable gonadotropins (Gonal-F, Menopur) for Clomid-resistant cases, combined with IUI for optimal results. Success rates for ovulation induction with IUI: 15-20% per cycle for unexplained infertility, mild male factor, or cervical factor.

Advanced Reproductive Surgery

Laparoscopic and hysteroscopic expertise treating structural fertility barriers: Endometriosis excision and ablation (stages I-IV) improving natural conception rates 50-70% depending on severity. Ovarian drilling for Clomid-resistant PCOS inducing ovulation in 80% of patients. Tubal repair for hydrosalpinx, fimbrioplasty for distal tubal disease restoring tubal patency. Myomectomy removing uterine fibroids while preserving fertility. Hysteroscopic polypectomy, septum resection, adhesiolysis correcting uterine cavity abnormalities. Minimally invasive approach ensures faster recovery, less scarring, improved fertility outcomes compared to open surgery.

Male Factor Fertility Management

Comprehensive male fertility evaluation and treatment often overlooked but essential—male factor contributes to 40-50% of infertility cases. Detailed semen analysis with strict WHO 2021 criteria. Hormonal evaluation (testosterone, FSH, LH, prolactin) if severe oligospermia or azoospermia. Antioxidant therapy (vitamin C, E, CoQ10, L-carnitine) improving sperm parameters 30-50% in 3-6 months. Lifestyle optimization: smoking cessation, alcohol reduction, weight loss, avoiding hot tubs/tight clothing. Urology referral for varicocele repair (varicocelectomy) improving semen quality 60-70% of cases. Coordination with andrologist for sperm retrieval procedures (TESE, MESA) if azoospermia requiring ICSI. Donor sperm counseling and coordination if severe irreversible male factor.

Frequently Asked Questions

Q1.When should we see a fertility specialist?

GENERAL GUIDELINE: Seek fertility evaluation after 12 months of regular unprotected intercourse without conception. "Regular" means 2-3 times weekly, especially during fertile window (5 days before and day of ovulation). EXCEPTIONS—Seek evaluation earlier if: AGE OVER 35: Evaluate after 6 months of trying. Ovarian reserve declines rapidly after 35—every month counts. AGE OVER 40: Immediate evaluation and treatment. Fertility drops sharply; time-sensitive intervention critical. KNOWN RISK FACTORS: Irregular or absent periods (likely ovulatory disorder requiring treatment). History of pelvic inflammatory disease, endometriosis, pelvic surgery (potential tubal damage). Known male factor: previous abnormal semen analysis, history of undescended testes, chemotherapy. Recurrent miscarriage: two or more consecutive losses warrant investigation before attempting again. Previous cancer treatment: chemotherapy or pelvic radiation affecting ovaries/testes. BOTTOM LINE: Don't wait if risk factors present or over 35. Early evaluation identifies treatable causes, maximizes success with simpler interventions, preserves fertility options. Even if "not ready" for treatment, baseline fertility assessment (AMH, semen analysis) provides valuable information for family planning decisions.

Q2.What causes infertility in women?

Female infertility factors account for 35-40% of cases (male factor 35-40%, combined 15-20%, unexplained 10-15%). OVULATORY DISORDERS (25-30% of female infertility): PCOS (most common): irregular ovulation, hormonal imbalances. Hypothalamic amenorrhea: stress, excessive exercise, low body weight suppressing GnRH. Premature ovarian insufficiency POI: early menopause before age 40. Hyperprolactinemia: elevated prolactin suppressing ovulation. Thyroid disorders: hypothyroidism or hyperthyroidism disrupting cycles. TUBAL DISEASE (20-25%): Pelvic inflammatory disease (PID) from chlamydia, gonorrhea causing scarring, blockage. Endometriosis: adhesions distorting pelvic anatomy, blocking tubes. Previous pelvic surgery: appendectomy, ovarian cyst removal, C-section with complications. Hydrosalpinx: fluid-filled blocked tube reducing IVF success 50% if not corrected. UTERINE FACTORS (10-15%): Fibroids: especially submucosal fibroids protruding into cavity impairing implantation. Polyps: endometrial growths interfering with embryo implantation. Asherman syndrome: intrauterine adhesions from D&C, infection, surgery. Congenital uterine anomalies: septate uterus, bicornuate uterus (often asymptomatic until conception attempts). CERVICAL FACTORS (rare, <5%): Cervical stenosis: narrowing from previous LEEP, cone biopsy. Antisperm antibodies: immunologic reaction destroying sperm. AGE-RELATED DECLINE (MOST SIGNIFICANT): Egg quality and quantity decrease with age. Fertility begins declining after age 32, accelerates after 35, steep drop after 40. Chromosomal abnormalities increase: higher miscarriage rates, lower pregnancy rates. OTHER FACTORS: Endometriosis (30-50% of women with endometriosis have infertility). Autoimmune conditions: antiphospholipid syndrome, lupus. Lifestyle: obesity (BMI >30), underweight (BMI <18.5), smoking, excessive alcohol. DIAGNOSIS REQUIRES: Comprehensive testing identifying specific cause(s) enabling targeted treatment.

Q3.What is ovulation induction and how successful is it?

Ovulation induction uses medications stimulating ovaries to develop and release eggs in women who don't ovulate regularly (anovulation) or ovulate infrequently (oligoovulation). INDICATIONS: PCOS (most common indication): 70-80% of PCOS women have ovulatory dysfunction. Hypothalamic amenorrhea: stress, weight loss, excessive exercise causing absent periods. Unexplained infertility: augmenting ovulation even if ovulating naturally (superovulation). FIRST-LINE MEDICATIONS: CLOMIPHENE CITRATE (Clomid): Oral medication, days 3-7 or 5-9 of cycle. Blocks estrogen receptors causing increased FSH production stimulating follicle development. Ovulation rate: 70-80% of PCOS women. Pregnancy rate: 20-30% per cycle over 3-6 cycles. Side effects: hot flashes, mood changes, cervical mucus thickening (can impair sperm penetration). LETROZOLE (Femara): Aromatase inhibitor reducing estrogen production, increasing FSH release. Preferred over Clomid for PCOS: higher live birth rates, lower multiple pregnancy risk. Ovulation rate: 75-85%. Pregnancy rate: 25-35% per cycle. Fewer side effects than Clomid. MONITORING: Transvaginal ultrasound days 10-12: tracking follicle development (target 18-22mm mature follicle). Bloodwork: estradiol levels (target 200-300 pg/ml per mature follicle avoiding hyperstimulation). TRIGGER INJECTION: hCG trigger (Pregnyl, Ovidrel) induces final egg maturation and ovulation 36-40 hours later. Timed intercourse: days of trigger, following day, and day after for optimal conception timing. Alternatively, IUI performed 24-36 hours post-trigger if male factor or cervical factor. SECOND-LINE MEDICATIONS (if Clomid/Letrozole fail): Injectable gonadotropins (Gonal-F, Menopur): Purified FSH/LH hormones directly stimulating ovaries. Higher ovulation and pregnancy rates but increased risk of multiples (20-30% twins, 5% triplets+) and OHSS. Require intensive monitoring: frequent ultrasounds, bloodwork, dose adjustments. Combined with IUI: pregnancy rates 15-20% per cycle. SUCCESS RATES: Cumulative pregnancy rate over 6 cycles of ovulation induction with timed intercourse: 50-60% for PCOS. With IUI: 60-70% over 3-6 cycles. If no pregnancy after 3-6 cycles despite confirmed ovulation: evaluation for other factors (tubal, male, uterine) and IVF consideration. RISKS: Multiple pregnancy (10-15% with Clomid, 20-30% with gonadotropins). OHSS (rare with Clomid, 1-5% with gonadotropins): ovarian enlargement, fluid accumulation, potentially serious. Cycle cancellation if too many follicles develop (>3-4) to prevent high-order multiples. BOTTOM LINE: Ovulation induction highly effective for anovulatory infertility. First-line treatment for PCOS achieving pregnancy in majority of women within 3-6 cycles. Careful monitoring essential for safety and optimizing success.

Q4.What is IUI and who is it recommended for?

Intrauterine insemination (IUI) places washed, concentrated sperm directly into uterus at time of ovulation bypassing cervix and positioning sperm closer to fallopian tubes where fertilization occurs. PROCEDURE: Sperm collection: partner produces sample (or donor sperm thawed) on day of procedure. Sperm washing: laboratory processing separates motile sperm from seminal fluid, removes debris, concentrates active sperm. Typically 10-20 million motile sperm used for insemination (vs 100+ million in ejaculate). Ovulation timing: natural cycle (tracking LH surge with predictor kits) or medicated cycle (Clomid, Letrozole, or gonadotropins with hCG trigger). Insemination: thin catheter inserted through cervix, sperm injected into uterine cavity. Painless, takes 5 minutes, no anesthesia needed. Post-IUI: rest 10-15 minutes, then resume normal activities. Progesterone support optional (vaginal suppositories) to optimize implantation. Pregnancy test: 14 days post-IUI. INDICATIONS: MILD MALE FACTOR: Mildly low sperm count (10-20 million/ml vs normal >15 million), slightly reduced motility (30-40% vs normal >40%), abnormal morphology (2-4% normal forms vs normal >4%). Sperm washing concentrates healthy sperm improving odds. UNEXPLAINED INFERTILITY: All testing normal but not conceiving. IUI with ovulation induction doubles pregnancy rates vs timed intercourse. CERVICAL FACTOR: Cervical mucus hostile to sperm (thick, acidic, antisperm antibodies). IUI bypasses cervix entirely. OVULATORY DYSFUNCTION: Combined with ovulation induction (Clomid, Letrozole) for PCOS, hypothalamic amenorrhea. ENDOMETRIOSIS (MILD): Stages I-II endometriosis may benefit from IUI + ovulation induction. DONOR SPERM: Single women, same-sex female couples, severe male factor infertility. SEXUAL DYSFUNCTION: Erectile dysfunction, vaginismus, retrograde ejaculation. SUCCESS RATES: Per cycle pregnancy rate: 10-20% depending on age, sperm quality, ovulation induction use. Age <35: 15-20% per cycle. Age 35-40: 10-15% per cycle. Age >40: 5-10% per cycle. Male factor severity impacts rates. Cumulative rate over 3-6 cycles: 30-50% live birth rate. Miscarriage rate similar to natural conception (15-20%). CONTRAINDICATIONS: Severe male factor: <5 million motile sperm post-wash (IVF with ICSI needed). Bilateral tubal blockage (IUI requires at least one open tube). Severe endometriosis (stages III-IV): IVF more effective. Age >42 with diminished ovarian reserve: IVF more efficient use of time. NUMBER OF CYCLES: Typically try 3-4 IUI cycles before moving to IVF if unsuccessful. 80-90% of pregnancies occur in first 3-4 attempts. COST: AED 1,500-3,000 per cycle in Dubai (including monitoring, sperm prep, insemination). Much less expensive than IVF (AED 15,000-25,000 per cycle). BOTTOM LINE: IUI is low-tech, relatively affordable fertility treatment suitable for mild-moderate infertility. Reasonable first-line option before IVF for appropriate candidates. Success depends on age, sperm quality, and tubal patency.

Q5.Does endometriosis cause infertility and how is it treated?

YES—endometriosis is found in 25-50% of infertile women and causes infertility through multiple mechanisms. 30-50% of women with endometriosis experience fertility problems. MECHANISMS CAUSING INFERTILITY: ANATOMIC DISTORTION: Adhesions and scarring distort pelvic anatomy displacing ovaries, tubes, uterus. Tubal obstruction or peritubal adhesions preventing egg pickup by fimbriae. Ovarian endometriomas (chocolate cysts) damaging surrounding healthy ovarian tissue reducing egg reserve. INFLAMMATION: Inflammatory mediators, cytokines, prostaglandins in peritoneal fluid creating hostile environment for sperm, egg, embryo. Macrophages in peritoneal fluid may phagocytose (destroy) sperm. ENDOCRINE EFFECTS: Anovulation or luteal phase defects in some cases. Altered hormonal milieu affecting egg quality, implantation. IMPLANTATION IMPAIRMENT: Endometrial inflammation affecting receptivity to embryo implantation. Altered expression of implantation markers (integrins, adhesion molecules). DIAGNOSIS: Laparoscopy: gold standard. Visualizes endometrial implants, adhesions, endometriomas. Biopsy confirms diagnosis histologically. Staging: minimal (stage I), mild (stage II), moderate (stage III), severe (stage IV) based on location, depth, adhesions. CA-125 blood test: often elevated but not diagnostic (also elevated in fibroids, PID, pregnancy). Imaging: Transvaginal ultrasound identifies endometriomas (blood-filled ovarian cysts). MRI: superior soft tissue characterization if ultrasound inconclusive. FERTILITY TREATMENT OPTIONS: EXPECTANT MANAGEMENT (minimal/mild endometriosis): If recently diagnosed, age <35, normal ovarian reserve, no other factors. Try naturally 6-12 months post-diagnosis. Spontaneous pregnancy rates 2-4.5% per month. LAPAROSCOPIC SURGERY: Excision or ablation of endometriosis implants, lysis of adhesions, removal of endometriomas improves natural conception rates. Success: 50-70% pregnancy rate within 12 months post-surgery for minimal-mild disease. 30-50% for moderate-severe disease. Ovarian drilling for associated PCOS. DOWNSIDE: Endometrioma removal may damage ovarian reserve (fewer eggs). Recurrence: 20-40% within 5 years. OVULATION INDUCTION + IUI: If surgery not desired/indicated or post-surgery without conception. Clomid or Letrozole + IUI: 10-15% pregnancy rate per cycle (slightly lower than unexplained infertility). 3-6 cycles attempted before IVF. IVF (In Vitro Fertilization): Most effective treatment for endometriosis-related infertility especially moderate-severe disease. Bypasses anatomic distortion and inflammatory environment. Pregnancy rates: 40-50% per cycle (age-dependent) comparable to other IVF indications. Recommended: Age >35-37 with stage III-IV endometriosis. Failed surgery or ovulation induction + IUI. Concomitant tubal damage or male factor. SUPPRESSION THERAPY (CONTROVERSIAL): GnRH agonists (Lupron), progestins (dienogest), or continuous birth control pills suppress endometriosis. DEBATE: Some studies show improved IVF outcomes after 3-6 months suppression pre-IVF. Other studies show no benefit. Not recommended as sole treatment for infertility—does not improve pregnancy rates during suppression (anovulation). NATURAL APPROACHES: Anti-inflammatory diet, omega-3 supplements, acupuncture: limited evidence but low risk, may help symptoms. PROGNOSIS: Minimal-mild endometriosis: Good prognosis with surgery or ovulation induction + IUI. Moderate-severe: Surgery beneficial but IVF often needed. Age significantly impacts outcomes—earlier intervention better. BOTTOM LINE: Endometriosis is common cause of infertility but treatable. Laparoscopic surgery improves natural conception for mild-moderate disease. IVF very effective for moderate-severe or failed conservative treatment. Early diagnosis and intervention maximize success. Don't delay evaluation if endometriosis diagnosed or suspected (pelvic pain, dysmenorrhea, dyspareunia).

Q6.How much does fertility treatment cost in Dubai?

Fertility treatment costs in Dubai vary widely based on specific interventions required. DIAGNOSTIC TESTING: Initial consultation: AED 800-1,200 (comprehensive history, exam, ultrasound). Hormonal testing panel (FSH, LH, estradiol, AMH, prolactin, TSH): AED 800-1,500. Semen analysis: AED 300-500 (two samples recommended). Hysterosalpingography (HSG) tubal test: AED 1,500-2,500. Sonohysterography (saline ultrasound): AED 1,000-1,800. Hysteroscopy (office): AED 2,500-4,000. Genetic testing (karyotype, carrier screening): AED 1,500-3,000 per person. OVULATION INDUCTION (per cycle): Clomiphene (Clomid) medication: AED 50-150 per cycle. Letrozole (Femara) medication: AED 100-200 per cycle. Monitoring (ultrasounds, bloodwork): AED 500-1,000 per cycle. hCG trigger injection: AED 200-500. Total per ovulation induction cycle: AED 1,000-2,000 (3-6 cycles typical). Injectable gonadotropins (Gonal-F, Menopur): AED 2,000-5,000 per cycle for medications. Total with monitoring: AED 3,000-7,000 per cycle. INTRAUTERINE INSEMINATION (IUI): IUI procedure (sperm wash + insemination): AED 1,500-2,500. With ovulation induction monitoring: AED 2,500-4,500 total per cycle. Donor sperm (if needed): AED 1,500-3,000 per vial. Typical recommendation: 3-4 IUI cycles = AED 7,500-18,000 total. SURGICAL TREATMENT: Diagnostic laparoscopy: AED 8,000-15,000. Laparoscopic endometriosis excision: AED 12,000-20,000. Laparoscopic myomectomy (fibroid removal): AED 15,000-25,000. Hysteroscopic polypectomy/septum resection: AED 8,000-12,000. Ovarian drilling (PCOS): AED 10,000-15,000. IVF/ICSI (REFERRAL TO SPECIALIZED CENTER): One IVF cycle: AED 15,000-28,000 (medications, egg retrieval, fertilization, transfer). ICSI (if severe male factor): add AED 3,000-5,000. Embryo freezing: AED 2,000-4,000 + AED 500-1,000/year storage. PGT (preimplantation genetic testing): AED 8,000-15,000. Frozen embryo transfer cycle: AED 6,000-10,000. CUMULATIVE COSTS (TYPICAL PATIENT JOURNEY): Conservative approach (ovulation induction only): AED 5,000-15,000 over 6 cycles. Moderate intervention (IUI x 3-4 cycles): AED 10,000-25,000. Surgical correction + IUI: AED 20,000-35,000. IVF pathway (if needed): AED 30,000-60,000 for 1-2 cycles. INSURANCE COVERAGE UAE: Highly variable—some plans cover diagnostic testing but exclude treatment. Mandatory to check policy specifics. Fertility treatment often excluded or capped (e.g., AED 10,000 lifetime maximum). Government insurance (Thiqa for UAE nationals): Covers some fertility services at approved centers. IVF: Very limited coverage; most plans exclude entirely. COST-EFFECTIVENESS CONSIDERATIONS: Age factor: Younger patients higher success rates with less expensive treatments (ovulation induction, IUI). Over 38-40: IVF may be more cost-effective than multiple IUI cycles (higher success per attempt). Specific diagnosis: Anovulation (PCOS) responds well to Clomid—inexpensive, highly effective. Tubal factor: IUI won't work—IVF necessary (don't waste money on ineffective treatment). Male factor severity: Mild-moderate responds to IUI; severe requires IVF-ICSI. RECOMMENDATION: Discuss cost-benefit with fertility specialist. Personalized treatment plan based on diagnosis, age, ovarian reserve optimizes success while minimizing unnecessary expense. Don't delay treatment due to cost—time (declining fertility with age) often more costly than upfront intervention. Many couples find fertility investment worthwhile—resulting in desired pregnancy and family.